Baron & Budd Attorney and Shareholder Burton LeBlanc to Speak on Opioid Epidemic at American Association for Justice
BATON ROUGE, La. – November 17, 2017 – The national law firm of Baron & Budd is pleased to...READ MORE
The FDA approved the Essure® Birth Control device and it became available to women in the U.S. in 2002. The manufacturer, Conceptus (now owned by Bayer), assured women that this device was safe and over 99% effective at preventing pregnancy. Essure® was advertised as a better choice because the procedure does not require general anesthesia, is less invasive, and has an average total procedure duration of 36 minutes. As a result, many women relied on the benefits of Essure®, as advertised, and chose Essure® as their method of permanent birth control.
A growing number of women disagree with the claims of safety. They have experienced a plethora of side effects and have received many adverse health diagnoses since choosing Essure®. Those conditions include:
Since its initial FDA approval there have been thousands of reports of dissatisfied users. Sufferers want to know why Essure’s® manufacturer did not warn women of the potential harm of their device. If doctors and patients had been fully informed of the risks involved, they would have made a different choice. It can be emotionally trying to realize that a device intended to help you has caused harm to your body and health. It can be further unnerving to realize that the choice you made was not as clear as it should have been because you were not given the complete information you were entitled to and needed.
The FDA recently called Bayer to account for failing to collect complete and appropriate data in clinical trials and failing to fully and timely report adverse events. If you have or had the Essure® device implanted and suffered complications as a result, contact us today at 866-750-3386 for a free evaluation. We are here to help.